Company / Operating Margin
Celldex Therapeutics, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-18599.8%
FY2025
5-year range
-18599.8% / -1531.8%
FY2021-FY2025
Trend
-569.3%
vs FY2024
Sector context
#147 of 148
Health Care
What the data says
Operating Margin changed -569% YoY in FY2025, a notable deviation from the 9-year average annual change of -111%.
Based on SEC 10-K filings.
-18599.8% in FY2025 with a 5-year CAGR of -17745.8%.
Declined from -2245.3% to -18599.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -13710.8pp
- 5-Year Change
- -17745.8pp
- 10-Year Change
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 148This company -18599.8% Sector average -284.5%
▼
-6438.8% below sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 569.3% year-over-year.
- Currently 18315.4pp below the Health Care sector average.
- Peak operating margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -18599.8% | -569.3% |
| FY2024 | -2778.9% | -23.8% |
| FY2023 | -2245.3% | +54.1% |
| FY2022 | -4889.0% | -219.2% |
| FY2021 | -1531.8% | -79.4% |
| FY2020 | -854.1% | +44.5% |
| FY2019 | -1540.2% | +21.4% |
| FY2018 | -1958.7% | +75.3% |
| FY2017 | -7922.2% | -304.5% |
| FY2016 | -1958.7% | +17.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026